FDANonrulemakingFDA-2015-N-3326
Who commented on this docket
Biosimilar User Fee Act
14 organizations filed 17 public comments on Biosimilar User Fee Act, at the Food and Drug Administration. The comment window closed 207d ago.
Organizations
14
Comments
17
RIN
—
Comment window
closed 207d ago
Commenters (14)
- Association for Accessible Medicinestrade assoc.3 filings · confidence 97%
- Arthritis Foundationtrade assoc.2 filings · confidence 85%
- American Federation of Statetrade assoc.1 filing · confidence 85%
- American Pharmacists Association (APhA)trade assoc.1 filing · confidence 97%
- Biologics Coalitiontrade assoc.1 filing · confidence 85%
- CELLTRION Inc.unverified attribution1 filing · confidence 70%
- Generic Pharmaceutical Association (GPhA) and Biosimilar Counciltrade assoc.1 filing · confidence 85%
- Generic Pharmaceutical Association (GPhA) and Biosimilars Counciltrade assoc.1 filing · confidence 85%
- Healthcare Supply Chain Associationtrade assoc.1 filing · confidence 85%
- Hepatitis Foundation Internationaltrade assoc.1 filing · confidence 85%
- National Consumers Leaguetrade assoc.1 filing · confidence 85%
- Pfenex Incunverified attribution1 filing · confidence 70%
- Pfizer Inc.unverified attribution1 filing · confidence 70%
- The Alliance for Safe Biologic Medicinestrade assoc.1 filing · confidence 85%
Attribution is name-based and imperfect. regulations.gov data is public record.